Livedoid vasculitis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 92: Line 92:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Obstetric/Gynecologic'''
| '''Obstetric/Gynecologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Anticardiolipin syndrome]], [[antiphospholipid syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"

Revision as of 14:57, 2 July 2014

WikiDoc Resources for Livedoid vasculitis

Articles

Most recent articles on Livedoid vasculitis

Most cited articles on Livedoid vasculitis

Review articles on Livedoid vasculitis

Articles on Livedoid vasculitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Livedoid vasculitis

Images of Livedoid vasculitis

Photos of Livedoid vasculitis

Podcasts & MP3s on Livedoid vasculitis

Videos on Livedoid vasculitis

Evidence Based Medicine

Cochrane Collaboration on Livedoid vasculitis

Bandolier on Livedoid vasculitis

TRIP on Livedoid vasculitis

Clinical Trials

Ongoing Trials on Livedoid vasculitis at Clinical Trials.gov

Trial results on Livedoid vasculitis

Clinical Trials on Livedoid vasculitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Livedoid vasculitis

NICE Guidance on Livedoid vasculitis

NHS PRODIGY Guidance

FDA on Livedoid vasculitis

CDC on Livedoid vasculitis

Books

Books on Livedoid vasculitis

News

Livedoid vasculitis in the news

Be alerted to news on Livedoid vasculitis

News trends on Livedoid vasculitis

Commentary

Blogs on Livedoid vasculitis

Definitions

Definitions of Livedoid vasculitis

Patient Resources / Community

Patient resources on Livedoid vasculitis

Discussion groups on Livedoid vasculitis

Patient Handouts on Livedoid vasculitis

Directions to Hospitals Treating Livedoid vasculitis

Risk calculators and risk factors for Livedoid vasculitis

Healthcare Provider Resources

Symptoms of Livedoid vasculitis

Causes & Risk Factors for Livedoid vasculitis

Diagnostic studies for Livedoid vasculitis

Treatment of Livedoid vasculitis

Continuing Medical Education (CME)

CME Programs on Livedoid vasculitis

International

Livedoid vasculitis en Espanol

Livedoid vasculitis en Francais

Business

Livedoid vasculitis in the Marketplace

Patents on Livedoid vasculitis

Experimental / Informatics

List of terms related to Livedoid vasculitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Livedo reticularis; livedo vasculitis; livedoid vasculopathy; primary livedo reticularis; idiopathic livedo reticularis; vitiligo reticularis

Overview

Livedoid vasculitis is a vascular disorder mostly affecting women. It may be aggravated by exposure to cold and occurs most often in the lower extremities. It can also be associated with the presence of anti-cardiolipin antibodies (the Antiphospholipid syndrome).

Historical Perspective

The condition's name derives from the Latin livere meaning bluish.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Causes by Organ System

Cardiovascular Antithrombin III deficiency, arteriosclerosis, Buerger's disease, carbon dioxide arteriography, cholesterol emboli syndrome, hypercalcemia, peripheral arterial occlusive disease, vasculitis
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic Cutis marmorata telangiectatica congenita, dermal vascular occlusion, dermatomyositis, FILS syndrome, idiopathic livedo reticularis, polyarteritis nodosa, scleroderma, Sneddon-Champion syndrome, systemic lupus erythematosus, vasculitis
Drug Side Effect Amantadine, dextroamphetamine, gefitinib, interferon beta treatment, methylphenidate, rasagiline
Ear Nose Throat No underlying causes
Endocrine Pheochromocytoma
Environmental No underlying causes
Gastroenterologic Pancreatitis
Genetic Cystathionine beta-synthase deficiency, Down syndrome, Ehlers-Danlos syndrome, familial primary cryofibrinogenemia, homocystinuria, oxalosis, plasminogen activator inhibitor-1 promoter homozygosity, protein C deficiency, prothrombin G20210A heterozygosity
Hematologic Anticardiolipin syndrome, antiphospholipid syndrome, antithrombin III deficiency, cryoglobulinemia, elevated fibrinopeptide A, factor V Leiden mutation, familial primary cryofibrinogenemia, Henoch-Schönlein purpura, increased plasminogen activator release, lupus anticoagulant, pernicious anemia, polycythaemia rubra vera, protein C deficiency, thrombocytosis
Iatrogenic Midline catheter
Infectious Disease Cytomegalovirus infection, Lyme disease, syphilis, tuberculosis
Musculoskeletal/Orthopedic Ehlers-Danlos syndrome, FILS syndrome, rheumatoid arthritis
Neurologic Anticardiolipin syndrome, antiphospholipid syndrome, mononeuritis multiplex, moyamoya disease, Sneddon-Champion syndrome
Nutritional/Metabolic Cystathionine beta-synthase deficiency, homocystinuria, hyperhomocysteinemia, primary hyperoxaluria
Obstetric/Gynecologic Anticardiolipin syndrome, antiphospholipid syndrome
Oncologic Lymphoma, metastatic breast carcinoma, pheochromocytoma, renal cell carcinoma
Ophthalmologic Cystathionine beta-synthase deficiency, homocystinuria
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary Churg-Strauss syndrome, sarcoidosis, scleroderma, tuberculosis
Renal/Electrolyte Henoch-Schönlein purpura, hypercalcemia, renal cell carcinoma, systemic lupus erythematosus
Rheumatology/Immunology/Allergy Anticardiolipin syndrome, antiphospholipid syndrome, Buerger's disease, Churg-Strauss syndrome, cryoglobulinemia, dermatomyositis, FILS syndrome, Henoch-Schönlein purpura, IgM antiphosphatidylserine-prothrombin complex antibody, immune complex disease, increased plasminogen activator release, lupus anticoagulant, mixed connective tissue disease, plasminogen activator inhibitor-1 promoter homozygosity, polyarteritis nodosa, polyclonal IgM hypergammopathy, rheumatoid arthritis, sarcoidosis, scleroderma, Sjögren's syndrome, systemic lupus erythematosus, vasculitis
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Silicone implants

Causes in Alphabetical Order

Treatment

Other than identifying and treating any underlying conditions in secondary livedo,[24] idiopathic livedo reticularis itself may improve with warming the legs, but once established the skin discolouration may become permanent.

References

  1. ↑ Gibbs MB, English JC, Zirwas MJ (2005). "Livedo reticularis: an update". J Am Acad Dermatol. 52 (6): 1009–19. doi:10.1016/j.jaad.2004.11.051. PMID 15928620.
  2. ↑ 2.0 2.1 2.2 2.3 Hairston BR, Davis MD, Pittelkow MR, Ahmed I (2006). "Livedoid vasculopathy: further evidence for procoagulant pathogenesis". Arch Dermatol. 142 (11): 1413–8. doi:10.1001/archderm.142.11.1413. PMID 17116831.
  3. ↑ Asherson RA, Cervera R (1993). "Antiphospholipid syndrome". J Invest Dermatol. 100 (1): 21S–27S. PMID 8423386.
  4. ↑ Gibson GE, Su WP, Pittelkow MR (1997). "Antiphospholipid syndrome and the skin". J Am Acad Dermatol. 36 (6 Pt 1): 970–82. PMID 9204065.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 Keller MS, Lee J, Webster GF (2008). "Livedoid thrombotic vasculopathy responding to doxycycline therapy". J Clin Aesthet Dermatol. 1 (4): 22–4. PMC 3016933. PMID 21212844.
  6. ↑ Johnson PL, Neperud J, Arnold J, Thomas J (2011). "Livedo reticularis and bowel ischemia after carbon dioxide arteriography in a patient with CREST syndrome". J Vasc Interv Radiol. 22 (3): 395–9. doi:10.1016/j.jvir.2010.11.012. PMID 21277800.
  7. ↑ Kazmier FJ, Sheps SG, Bernatz PE, Sayre GP (1966). "Livedo reticularis and digital infarcts: a syndrome due to cholesterol emboli arising from atheromatous abdominal aortic aneurysms". Vasc Dis. 3 (1): 12–24. PMID 5903590.
  8. ↑ Stewart WM, Lauret P, Testart J, Thomine E, Boulliê MC, Leroy D (1977). "[Cutaneous cholesterol emboli (author's transl)]". Ann Dermatol Venereol. 104 (1): 5–8. PMID 843026.
  9. ↑ Namazi MR, Kerchner KR, Pichardo RO (2008). "Essential type II mixed cryoglobulinemia causing pyoderma gangrenosum-like ulcers". ScientificWorldJournal. 8: 228. doi:10.1100/tsw.2008.44. PMID 18335149.
  10. ↑ Pachlopnik Schmid J, Lemoine R, Nehme N, Cormier-Daire V, Revy P, Debeurme F; et al. (2012). "Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature ("FILS syndrome")". J Exp Med. 209 (13): 2323–30. doi:10.1084/jem.20121303. PMC 3526359. PMID 23230001.
  11. ↑ Helander SD, De Castro FR, Gibson LE (1995). "Henoch-Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis". Acta Derm Venereol. 75 (2): 125–9. PMID 7604640.
  12. ↑ Fox M, Tahan S, Kim CC (2012). "Livedo reticularis: a side effect of interferon therapy in a pediatric patient with melanoma". Pediatr Dermatol. 29 (3): 333–5. doi:10.1111/j.1525-1470.2011.01426.x. PMID 21575046.
  13. ↑ Cruz BA, Queiroz ED, Nunes SV, Cruz Filho A, Campos GB, Monteiro EL; et al. (2000). "[Severe Raynaud's phenomenon associated with interferon-beta therapy for multiple sclerosis: case report]". Arq Neuropsiquiatr. 58 (2B): 556–9. PMID 10920422.
  14. ↑ Rot U, Ledinek AH (2013). "Interferons beta have vasoconstrictive and procoagulant effects: a woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis". Clin Neurol Neurosurg. 115 Suppl 1: S79–81. doi:10.1016/j.clineuro.2013.09.027. PMID 24321162.
  15. ↑ Stephansson EA, Niemi KM, Jouhikainen T, Vaarala O, Palosuo T (1991). "Lupus anticoagulant and the skin. A longterm follow-up study of SLE patients with special reference to histopathological findings". Acta Derm Venereol. 71 (5): 416–22. PMID 1684471.
  16. ↑ Oh YB, Jun JB, Kim CK, Lee CW, Park CK, Kim TY; et al. (2000). "Mixed connective tissue disease associated with skin defects of livedoid vasculitis". Clin Rheumatol. 19 (5): 381–4. PMID 11055828.
  17. ↑ Toth C, Trotter M, Clark A, Zochodne D (2003). "Mononeuropathy multiplex in association with livedoid vasculitis". Muscle Nerve. 28 (5): 634–9. doi:10.1002/mus.10450. PMID 14571469.
  18. ↑ Gould JW, Helms SE, Schulz SM, Stevens SR (1998). "Relapsing livedo reticularis in the setting of chronic pancreatitis". J Am Acad Dermatol. 39 (6): 1035–6. PMID 9843029.
  19. ↑ SIGMUND WJ, SHELLEY WB (1954). "Cutaneous manifestations of acute pancreatitis, with special reference to livedo reticularis". N Engl J Med. 251 (21): 851–3. doi:10.1056/NEJM195411182512104. PMID 13214346.
  20. ↑ Buckley, Sarah A.; Lessing, Juan N.; Mark, Nicholas M. (2013). "Livedo Reticularis in a Patient With Pheochromocytoma Resolving After Adrenalectomy". The Journal of Clinical Endocrinology & Metabolism. 98 (2): 439–440. doi:10.1210/jc.2012-2842. ISSN 0021-972X.
  21. ↑ Boyvat A, Kundakçi N, Babikir MO, Gürgey E (2000). "Livedoid vasculopathy associated with heterozygous protein C deficiency". Br J Dermatol. 143 (4): 840–2. PMID 11069468.
  22. ↑ Thomas JR, Winkelmann RK (1983). "Vascular ulcers in scleroderma". Arch Dermatol. 119 (10): 803–7. PMID 6137196.
  23. ↑ Yasue T (1986). "Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus". Arch Dermatol. 122 (1): 66–70. PMID 3942409.
  24. ↑ Fleischer A, Resnick S (1990). "Livedo reticularis". Dermatol Clin. 8 (2): 347–54. PMID 2191805.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Livedoid_vasculitis&oldid=985538"